Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.
07.05.2025 14:48:53

Medacta announces the results of today's Annual General Meeting

Medacta Group SA / Key word(s): AGMEGM
Medacta announces the results of today's Annual General Meeting

07.05.2025 / 14:48 CET/CEST


Media Release   

Medacta announces the results of today's Annual General Meeting 

  • All proposals of the Board of Directors were approved
  • The distribution of around CHF 13.7 million, or CHF 0.69 per share, was approved
  • Dr. Alberto Siccardi as Chair of the Board of Directors and all other Board members standing for re-election were confirmed  

CASTEL SAN PIETRO, Switzerland, 7 May 2025Medacta Group SA (“Medacta”, SIX:MOVE) today announced that its shareholders approved all proposals made by the Board of Directors at today's Annual General Meeting (“AGM”) .

Today's AGM was held with the physical participation of shareholders and took place at the Group premises in Via alla Rossa 6, Rancate - Switzerland. A total  of 17,881,923 shares were represented, either by attending shareholders or by third-party proxy and by the independent proxy, corresponding to approximately 89.41% of Medacta's share capital.

Shareholders approved the distribution of around CHF 13.7 million, or CHF 0.69 per share, half of it to be distributed as dividend out of available earnings and half of it to be distributed out of accumulated reserves from capital contribution.

Alberto Siccardi, Maria Luisa Siccardi Tonolli, Victor Balli, Riccardo Braglia and Philippe Weber were each re-elected as members of the Board of Directors for one-year term of office and Alberto Siccardi was re-elected as chairman of the Board. Medacta's shareholders also re-elected Philippe Weber and Riccardo Braglia as members of the Remuneration Committee for a term of one year.

Further proposals by the Board of Directors that were approved at today's AGM included the following:

  • The approval of the Management Report, the Annual Statutory Financial Statements and the Consolidated Financial Statements for the financial year 2024;
  • The approval of the 2024 Report on non-financial matters;
  • The approval of the Remuneration Report for the financial year 2024;
  • The approval of the appropriation of available earnings as of 31 December 2024 of Medacta Group SA for the financial year 2024;
  • The discharge of the members of the Board of Directors and the Executive Management;
  • The re-election of the independent proxy and the auditors;
  • The maximum aggregate compensations of the Board of Directors and the members of the Executive Management;

The minutes of the 2025 AGM will be available in due course at:
https://www.medacta.com/EN/agm

 

Contact

Medacta International
Anja Pomrehn
Group VP Sustainability and Investor & Media Relations
Telephone: +41 91 696 14 95
Email: pomrehn@medacta.ch

 

About Medacta
Medacta is a global key player specializing in the design, production, and distribution of innovative, personalized, and sustainable solutions for joint replacement, sports medicine, and spine surgery. Established in 1999 in Switzerland, Medacta is committed to improving the care and well-being of patients and maintains a strong focus on healthcare sustainability. Through close collaboration with expert surgeons globally, continuous investments in R&D, and the adoption of cutting-edge technologies, Medacta’s innovation prioritizes minimally invasive surgery and personalized solutions for every patient. Through the M.O.R.E. Institute, Medacta supports surgeons with a comprehensive and tailored program dedicated to the advancement of medical education. Medacta is headquartered in Castel San Pietro, Switzerland, and operates in over 60 countries. Follow us on Medacta.com, Medacta TV, YouTube, LinkedIn and X.

 



End of Media Release


Language: English
Company: Medacta Group SA
Strada Regina
6874 Castel San Pietro
Switzerland
Phone: +41 91 696 6060
E-mail: info@medacta.ch
Internet: www.medacta.com
ISIN: CH0468525222
Listed: SIX Swiss Exchange
EQS News ID: 2132324

 
End of News EQS News Service

2132324  07.05.2025 CET/CEST

Analysen zu Medacta

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
Zu diesem Datensatz liegen uns leider keine Daten vor.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Die David-Schere erklärt: 5 Kennzahlen für starke Aktien – am Beispiel von SAP

Seit Anfang 2023 präsentieren der Investment-Stratege François Bloch und Börsenexperte David Kunz jeweils drei sorgfältig ausgewählte Aktien im BX Morningcall.
Eine Begrifflichkeit, die im Zusammenhang mit der Titelauswahl immer wieder fällt, ist die «David-Schere».

Was verbirgt sich hinter der #David-Schere? In diesem Video erklärt François Bloch, warum diese Methode zur #Aktienbewertung eine echte Geheimwaffe ist – und was sie so treffsicher macht.
Gemeinsam mit David Kunz nehmen wir den Technologiegiganten #SAP unter die Lupe und zeigen anhand von fünf Kennzahlen, warum diese Aktie derzeit besonders spannend ist.:

✅ Umsatz
✅ EBIT
✅ EBIT Marge
✅ Dividende
✅ Gewinn pro Aktie

Pünktlich zum Börsenstart diskutieren Investment-Stratege François Bloch und Börsen-Experte David Kunz oder Olivia Hähnel über ausgewählte Top-Aktienwerte aus dem BX Musterportfolio.

👉🏽 https://bxplus.ch/bx-musterportfolio/

Die David-Schere erklärt: 5 Kennzahlen für starke Aktien – am Beispiel von SAP

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 12’714.56 18.74 B0LSNU
Short 12’947.44 13.50 SS4MTU
Short 13’417.78 8.81 BDGS0U
SMI-Kurs: 12’061.72 08.05.2025 17:31:25
Long 11’740.00 19.83
Long 11’480.00 13.84
Long 11’040.00 8.82
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

Aktien in diesem Artikel

Medacta 140.00 4.17% Medacta

Börse aktuell - Live Ticker

Nach "Trade Deal" von Trump: Japanische Börse legt zu

Die wichtigsten asiatischen Indizes präsentieren sich am Freitag mit gemischten Vorzeichen. Der heimische Aktienmarkt zeigte sich am Donnerstag tiefer, der deutsche Aktienmarkt legte zu. Die US-Börsen schlossen am Donnerstag deutlich im Plus.

finanzen.net News

Datum Titel
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
{{ARTIKEL.NEWS.BODY.TITEL}}